3DPOD Episode 71: Formlabs COO Jason Fullmer
Jason Fullmer is the COO of Formlabs. We spoke to him about the company’s global supply chain, including sourcing, interruptions, reverse logistics, shipping, quality assurance, quality management and many more topics. Operations and supply chain are super important to businesses, but we often overlook this importance and focus on the more obvious sides of a businesses, such as their marketing or strategies. A good idea is nothing without execution and excellence in operations. We hope that a look at some aspects of supply chain and quality will make this a handy and interesting talk for you.
Podcast (podcast-audio): Play in new window | Download
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
You May Also Like
Japan Ground Self-Defense Force Buys SPEE3D Metal 3D Printers
SPEE3D, the Australian original equipment manufacturer (OEM) of cold spray additive manufacturing (CSAM) platforms, has been awarded a contract by the Japanese Ministry of Defense to purchase both WarpSPEE3D and...
Toyota Taps SOLIZE to 3D Print Functional Parts for Lexus
Recently, Japanese reseller and 3D printing service SOLIZE has achieved notable success. In 2021, the company began manufacturing 3D printed components for Nissan’s NISMO brand, utilizing HP printers. Now, SOLIZE...
3DPOD Episode 168: Reselling 3D Printers in Japan, Korea and the USA with Douglas Krone, Brule and Dynamism
Douglas Krone co-founded Dynamism, a reseller specializing in a range of 3D printers, from desktop to industrial models, for the U.S. market. This successful enterprise has become a leader in...
Japan’s Largest Fishing Company to Fast-Track Lab-Grown Fish via Seafood 3D Printing Firm Investment
Maruha Nichiro (TYO: 1333), Japan’s largest fishing company, has announced a strategic investment and collaborative partnership with Singapore-based Umami Bioworks (formerly known as Umami Meats) to develop and commercialize cell-cultivated...
